SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violat...
May 27 2016 - 2:59PM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Gilead Sciences Inc. (“Gilead Sciences” or the “Company”)
(NASDAQ:GILD) concerning possible violations of federal securities
laws.
On May 6, 2016, Gilead acknowledged receipt of a subpoena from
the U.S. Attorney’s Office for the District of Massachusetts in
February 2016. According to the Company, the subpoena requested
documents related to the Company’s “support of 501(c)(3)
organizations that provide financial assistance to patients, and
for our HCV products, documents concerning our provision of
financial assistance to patients.” Then on May 27, 2016, Bloomberg
reported that Gilead is one of three major drugmakers to disclose
in a recent SEC filing the receipt of a subpoena as part of this
expanding federal investigation. To obtain additional information
about the investigation, go to:
http://zlk.9nl.com/gilead-sciences-gild
or contact Eduard Korsinsky, Esq. either via email at ek@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation involving financial
fraud, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160527005784/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.30 Broad Street -
24th FloorNew York, NY 10004Tel: 212-363-7500Toll Free:
877-363-5972Fax: 212-363-7171www.zlk.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024